Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Skin Disorders”

488 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 488 results

Early research (Phase 1)UnknownNCT02457650
What this trial is testing

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Who this might be right for
Bladder CarcinomaBreast CancerEsophagus Carcinoma+7 more
Shenzhen Second People's Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Testing effectiveness (Phase 2)UnknownNCT05792410
What this trial is testing

A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.

Who this might be right for
HER2 Low Advanced or Metastatic Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 300
Early research (Phase 1)Ended earlyNCT07121829
What this trial is testing

Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorPilocytic Astrocytoma+7 more
Day One Biopharmaceuticals, Inc. 44
Not applicableStudy completedNCT02364388
What this trial is testing

IMAging With Opto-acoustics to downgradE BI-RADS claSsificaTion Relative tO Other Diagnostic Methodologies (MAESTRO)

Who this might be right for
Breast Cancer
Seno Medical Instruments Inc. 217
Testing effectiveness (Phase 2)Active Not RecruitingNCT04538742
What this trial is testing

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AstraZeneca 245
Not applicableStudy completedNCT01413061
What this trial is testing

Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft

Who this might be right for
Degenerative OsteoarthritisPost-traumatic; ArthrosisRheumatoid Arthritis & Other Inflammatory Polyarthropathies+1 more
AlloSource 140
Large-scale testing (Phase 3)Study completedNCT00810199
What this trial is testing

Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 556
Testing effectiveness (Phase 2)Looking for participantsNCT06324357
What this trial is testing

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Who this might be right for
Metastatic Breast CancerMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Boehringer Ingelheim 768
Not applicableStudy completedNCT00002272
What this trial is testing

An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies

Who this might be right for
Herpes SimplexHIV Infections
Astra USA
Early research (Phase 1)Active Not RecruitingNCT04188548
What this trial is testing

LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

Who this might be right for
Breast CancerAdvanced Breast CancerMetastatic Breast Cancer+1 more
Eli Lilly and Company 379
Early research (Phase 1)Study completedNCT04670679
What this trial is testing

A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 90
Not applicableStudy completedNCT02157090
What this trial is testing

Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product.

Who this might be right for
Herpes Simplex Labialis
Technische Universität Dresden
Early research (Phase 1)Ended earlyNCT06799533
What this trial is testing

Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors

Who this might be right for
Malignant MelanomaMelanomaMetastatic Melanoma+1 more
Pfizer 11
Large-scale testing (Phase 3)UnknownNCT00577304
What this trial is testing

A Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Other Autoimmune Disease
MediQuest Therapeutics 200
Post-approval studies (Phase 4)UnknownNCT04885751
What this trial is testing

Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy

Who this might be right for
Rheumatoid ArthritisOsteoarthritisAnkylosing Spondylitis+5 more
Seoul National University Boramae Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02474186
What this trial is testing

Phase II Study for Solid Metastatic Tumors

Who this might be right for
Breast CancerMetastatic Breast CancerSolid Tumor
NYU Langone Health 41
Large-scale testing (Phase 3)Study completedNCT00647270
What this trial is testing

Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing

Who this might be right for
Rheumatoid Arthritis
Abbott 420
Testing effectiveness (Phase 2)Looking for participantsNCT06369831
What this trial is testing

HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011

Who this might be right for
Metastatic Breast CancerMetastatic Solid Cancer
Abscint NV/SA 60
Testing effectiveness (Phase 2)Ended earlyNCT01624090
What this trial is testing

Mithramycin for Lung, Esophagus, and Other Chest Cancers

Who this might be right for
Lung CancerEsophageal CancerMesothelioma+2 more
National Cancer Institute (NCI) 16
Next Page